Recently, somatostatin receptor 2 (SSTR2) and insulin-like growth factor 1 receptor (IGF-1R) have been reported to be expressed in breast cancer [5-8], and several clinical trials of SSAs in breast cancer have been conducted. This evidence concerns the gene IGF1R and breast carcinoma.